Cohance Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences (formerly Suven Pharmaceuticals) has submitted copies of newspaper advertisements containing its unaudited financial results for the quarter ended June 30, 2025. The ads were published on August 14, 2025 in Business Standard (English) and Lokmat (Marathi), as required under SEBI Listing Regulations. This is a routine compliance filing to publicly disseminate the Q1 results already filed with the exchanges. The company also hosted the advertisements on its website. Note: The actual financial figures for Cohance are not visible in the document text; only results of other companies (Pfizer, Ecos India, Kalpataru) appear in the newspaper clipping provided.
No new information for shareholders — this is a standard regulatory disclosure confirming that Q1 FY26 results have been published in newspapers. The actual financial numbers were already disclosed when results were filed with the exchanges.